Cavallaro G, Filippi L, Bagnoli P, La Marca G, Cristofori G, Raffaeli G, Padrini L, Araimo G, Fumagalli M, Groppo M, Dal Monte M, Osnaghi S, Fiorini P, Mosca F (2014) The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge. Acta Ophthalmol 92:2–20. https://doi.org/10.1111/aos.12049
Article CAS PubMed Google Scholar
Hellström A, Smith LE, Dammann O (2013) Retinopathy of prematurity. Lancet 382:1445–1457
Article PubMed PubMed Central Google Scholar
Hundscheid TM, Gulden S, Almutairi MF, Bartoš F, Cavallaro G, Villamor E (2023) Sex differences in the risk of retinopathy of prematurity: a systematic review, frequentist and bayesian meta-analysis, and meta-regression. World J Pediatr. https://doi.org/10.1007/s12519-023-00775-x
Article PubMed PubMed Central Google Scholar
Villamor-Martinez E, Cavallaro G, Raffaeli G, Mohammed Rahim OMM, Gulden S, Ghazi AMT, Mosca F, Degraeuwe P, Villamor E (2018) Chorioamnionitis as a risk factor for retinopathy of prematurity: an updated systematic review and meta-analysis. PLoS ONE 13:e0205838. https://doi.org/10.1371/journal.pone.0205838
Article CAS PubMed PubMed Central Google Scholar
Lofqvist C, Andersson E, Sigurdsson J, Engstrom E, Hard AL, Niklasson A, Smith LE, Hellstrom A (2006) Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity. Arch Ophthalmol 124:1711–1718. https://doi.org/10.1001/archopht.124.12.1711
Schalij-Delfos NE, Zijlmans BLM, Cats BP (1996) Towards a universal approach for screening of retinopathy of prematurity (ROP). Doc Ophthalmol 92:137–144. https://doi.org/10.1007/BF02583285
Thomas K, Shah PS, Canning R, Harrison A, Lee SK, Dow KE (2015) Retinopathy of prematurity: risk factors and variability in Canadian neonatal intensive care units. J Neonatal Perinat Med 8:207–214. https://doi.org/10.3233/NPM-15814128
Kim SJ, Port AD, Swan R, Campbell JP, Chan RP, Chiang MF (2018) Retinopathy of prematurity: a review of risk factors and their clinical significance. Surv Ophthalmol 63:618–637
Article PubMed PubMed Central Google Scholar
Torres-Cuevas I, Parra-Llorca A, Sánchez-Illana A, Nuñez-Ramiro A, Kuligowski J, Cháfer-Pericás C, Cernada M, Escobar J, Vento M (2017) Oxygen and oxidative stress in the perinatal period. Redox Biol 12:674–681
Article CAS PubMed PubMed Central Google Scholar
Lorente-Pozo S, Parra-Llorca A, Lara-Cantón I, Solaz A, García-Jiménez JL, Pallardó FV, Vento M (2020) Oxygen in the neonatal period: oxidative stress, oxygen load and epigenetic changes. Seminars in fetal and neonatal medicine. Elsevier, p 101090
Buonocore G, Perrone S, Bracci R (2001) Free radicals and brain damage in the newborn. Biol Neonate 79:180–186. https://doi.org/10.1159/000047088
Article CAS PubMed Google Scholar
Giuffre M, Rizzo M, Scaturro G, Pitruzzella A, Marino Gammazza A, Cappello F, Corsello G, Li Volti G (2015) Oxidative stress markers at birth: analyses of a neonatal population. Acta Histochem 117:486–491. https://doi.org/10.1016/j.acthis.2015.01.007
Article CAS PubMed Google Scholar
van Westering-Kroon E, Huizing MJ, Villamor-Martinez E, Villamor E (2021) Male disadvantage in oxidative stress-associated complications of prematurity: a systematic review, meta-analysis and meta-regression. Antioxid (Basel) 10:1490. https://doi.org/10.3390/antiox10091490
Dani C, Poggi C, Pratesi S (2019) Bilirubin and oxidative stress in term and preterm infants. Free Radic Res 53:2–7
Article CAS PubMed Google Scholar
Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN (1987) Bilirubin is an antioxidant of possible physiological importance. Science 235:1043–1046. https://doi.org/10.1126/science.3029864
Article CAS PubMed Google Scholar
Baranano DE, Rao M, Ferris CD, Snyder SH (2002) Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA 99:16093–16098. https://doi.org/10.1073/pnas.252626999
Article CAS PubMed PubMed Central Google Scholar
Wang WW, Smith DL, Zucker SD (2004) Bilirubin inhibits iNOS expression and NO production in response to endotoxin in rats. Hepatology 40:424–433. https://doi.org/10.1002/hep.20334
Article CAS PubMed Google Scholar
Lanone S, Bloc S, Foresti R, Almolki A, Taille C, Callebert J, Conti M, Goven D, Aubier M, Dureuil B, El-Benna J, Motterlini R, Boczkowski J (2005) Bilirubin decreases nos2 expression via inhibition of NAD(P)H oxidase: implications for protection against endotoxic shock in rats. FASEB J 19:1890–1892. https://doi.org/10.1096/fj.04-2368fje
Article CAS PubMed Google Scholar
Bélanger S, Lavoie J-C, Chessex P (1997) Influence of bilirubin on the antioxidant capacity of plasma in newborn infants. Neonatology 71:233–238
Gopinathan V, Miller NJ, Milner AD, Rice-Evans CA (1994) Bilirubin and ascorbate antioxidant activity in neonatal plasma. FEBS Lett 349:197–200
Article CAS PubMed Google Scholar
Sedlak TW, Snyder SH (2004) Bilirubin benefits: cellular protection by a biliverdin reductase antioxidant cycle. Pediatrics 113:1776–1782
Heyman E, Ohlsson A, Girschek P (1989) Retinopathy of prematurity and bilirubin. N Engl J Med 320:256. https://doi.org/10.1056/nejm198901263200420
Article CAS PubMed Google Scholar
Yeo KL, Perlman M, Hao Y, Mullaney P (1998) Outcomes of extremely premature infants related to their peak serum bilirubin concentrations and exposure to phototherapy. Pediatrics 102:1426–1431. https://doi.org/10.1542/peds.102.6.1426
Article CAS PubMed Google Scholar
Kao JS, Dawson JD, Murray JC, Dagle JM, Berends SK, Gillen SB, Bell EF (2011) Possible roles of bilirubin and breast milk in protection against retinopathy of prematurity. Acta Paediatr 100:347–351. https://doi.org/10.1111/j.1651-2227.2010.02069.x
Fereshtehnejad SM, Poorsattar Bejeh Mir K, Poorsattar Bejeh Mir A, Mohagheghi P (2012) Evaluation of the possible antioxidative role of bilirubin protecting from free radical related illnesses in neonates. Acta Med Iran 50:153–163
Romeo M, Tina L, Scuderi A, Di Pietro A, Caracciolo M, Distefano G (1994) Variations of blood bilirubin levels in the newborn with and without retinopathy of prematurity (ROP). Pediatr Med Chir Med Surg Pediatr 16:59–62
Milner JD, Aly HZ, Ward LB, El-Mohandes A (2003) Does elevated peak bilirubin protect from retinopathy of prematurity in very low birthweight infants. J Perinatol 23:208–211. https://doi.org/10.1038/sj.jp.7210887
Weintraub Z, Carmi N, Elouti H, Rumelt S (2011) The association between stage 3 or higher retinopathy of prematurity and other disorders of prematurity. Can J Ophthalmol J Canadien D Ophtalmologie 46:419–424. https://doi.org/10.1016/j.jcjo.2011.07.014
Gaton DD, Gold J, Axer-Siegel R, Wielunsky E, Naor N, Nissenkorn I (1991) Evaluation of bilirubin as possible protective factor in the prevention of retinopathy of prematurity. Br J Ophthalmol 75:532–534. https://doi.org/10.1136/bjo.75.9.532
Article CAS PubMed PubMed Central Google Scholar
Fauchère JC, Meier-Gibbons FE, Koerner F, Bossi E (1994) Retinopathy of prematurity and bilirubin–no clinical evidence for a beneficial role of bilirubin as a physiological anti-oxidant. Eur J Pediatr 153:358–362. https://doi.org/10.1007/bf01956419
留言 (0)